ClinicalTrials.Veeva

Menu

Liver Transplant Recipients and 30-Second Lie-to-Sit Test

I

Inonu University

Status

Enrolling

Conditions

Liver Transplant Recipients

Treatments

Other: Trunk extension strength
Other: 30-second sit-to-stand test
Other: waist circumference
Other: Upper Extremity Functional Index-15 (UEFI-15)
Other: Quadriceps muscle strength
Other: 2-minute walk test
Other: Deltoid muscle strength
Other: Handgrip strength
Other: 30-second lie-to-sit test
Other: Trunk flexion strength
Other: Modified Borg Scale
Other: Lower Extremity Functional Scale (LEFS)

Study type

Observational

Funder types

Other

Identifiers

NCT07365098
2025/8550

Details and patient eligibility

About

The aim of this study is to assess functional capacity in liver transplant recipients using the 30-second lie-to-sit test and to examine the relationships between functional capacity and variables such as muscle strength, upper and lower extremity function, exercise capacity, and perceived exertion.

Full description

Participants' demographic and clinical characteristics, including age, gender, BMI, waist circumference, and relevant clinical data, will be recorded. Functional capacity will also be assessed using the 30-second sit-to-stand test, the 2-minute walk test, and upper and lower extremity functional scales (UEFI-15, AEFÖ), with perceived exertion measured using the Modified Borg Scale. Muscle strength will be measured isometrically with a dynamometer for the quadriceps, deltoid, trunk flexor/extensor muscles, and handgrip. The obtained data will provide a comprehensive evaluation of muscle strength and functional status, contributing to individualized rehabilitation planning.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18-65 years
  • Diagnosed with end-stage liver disease and listed for liver transplantation
  • Ability to speak, understand, and write in Turkish
  • No mental disorders
  • Voluntary participation with informed consent

Exclusion criteria

  • Pulmonary, neurological, or cardiac diseases that may interfere with adherence to the assessment protocol
  • Difficulty complying with the assessment program
  • Musculoskeletal problems
  • History of regular physical activity
  • Multiple organ failure
  • Cognitive impairment

Trial contacts and locations

1

Loading...

Central trial contact

İrem Yiğit; Büşra CANDİRİ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems